Human medicines European public assessment report (EPAR): Icatibant Accord, icatibant, Date of authorisation: 16/07/2021, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 16 April 2026 - 11:16

Human medicines European public assessment report (EPAR): Icatibant Accord, icatibant, Date of authorisation: 16/07/2021, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 16 April 2026 - 11:06

Human medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 1, Status: Authorised

Survey: Intermediate Care Units (IMCU) Perspective of Internists

Submitted by Catalina on 16 April 2026 - 10:31

Dear Colleagues, 

On behalf of the Acute Medicine and Hospitalism EFIM Working Group, we are conducting a survey to better understand how Intermediate Care Units (IMCUs) are organised and integrated within acute and internal medicine services.

The aim of this initiative is to collect practical insights from national societies in order to:

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness